Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference Pharmaceutical Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, HEPS, PTON and Z Pharmaceutical Investing
BMY, LSPD SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set Pharmaceutical Investing
Health Canada Approves KEYTRUDA® in Combination with Chemotherapy for the Treatment of Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1 Pharmaceutical Investing
Trodelvy® Granted European Commission Marketing Authorization for Treatment of Metastatic Triple-Negative Breast Cancer in Second Line Pharmaceutical Investing
HealthTab to Offer Abbott's i-STAT Alinity, Expanding Chronic Disease Testing to Select Community Pharmacies in Canada Pharmaceutical Investing
Love Pharma Signs Letter of Intent to Acquire 100% Interest in MicrDoz Therapy Inc. To Expedite Pilot Study of Psilocybin Assisted Treatment of Cannabis Use Disorder with World Leading University Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval of Zeposia for use in Adults with Moderately to Severely Active Ulcerative Colitis Pharmaceutical Investing
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BMY, CTXS, OWLT INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
